Logout Login Cart iconShop Contact Sales

Search

Filters

Content Type

Products

Clear Filters

Search Results for "tangenX"

Looking for quality documents?
webpage icon
Legal
Repligen.com Terms of Use and Safe Harbor Statement. Repligen assumes no obligation to update any forward-looking information contained in this web site or with respect to the announcements described herein.
webpage icon
Bioprocess International Conference 2023
corporate icon
TangenX® SIUS® Gamma TFF Devices
With the performance and efficiency of SIUS® Cassettes, SIUS Gamma Devices come as a convenient, fully assembled, closed, and sterile system.
webpage icon
KrosFlo® KMPi Tangential Flow Filtration (TFF) Systems | Repligen
Fully automate 100 ml - 500 L UF/DF processes using an unparalleled combination of hardware integration with peristaltic pump, configurability and automation through modular, plug-and-play hardware.
video icon
TFF genius
You’re not asking for too much. Combine high selectivity and reduced processing time. Become a TFF genius and get it all with TangenX® Membranes and TFF Devices.
webpage icon
Leadership
Repligen Leadership. Meet our Officers, Functional leaders, and Board of Directors.
publications icon
TangenX SC TFF Device Regulatory Support File
external link icon
UPDATE -- Repligen Acquires TangenX Technology Corporation
WALTHAM, Mass., Dec. 15, 2016 (GLOBE NEWSWIRE) - Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it has acquired TangenX Technology Corporation (“TangenX”) of Shrewsbury, MA, maker of the innovative single-use Sius™ line of tangential flow filtration (“TFF”) cassettes and hardware used in downstream biopharmaceutical manufacturing processes.  Sius TFF is used in the filtration of biological drugs, complementing Repligen’s OPUS® line of Pre-Packed Chromatography Columns used in downstream purification. Single-use Sius TFF cassettes are designed to deliver superior performance to traditional (reusable) TFF cassettes in a cost-competitive format that provides user-ready convenience and flexibility. The Sius portfolio also strengthens the Company’s existing capability in filtration, where its XCell™ ATF products (both stainless steel and
external link icon
Repligen Launches TangenX® SC as First-to-Market Holder-Free Self-Contained TFF Device
- Targeting ADC and Cell & Gene Therapy Customers - WALTHAM, Mass., Nov. 02, 2023 (GLOBE NEWSWIRE) - Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the commercial launch of TangenX® SC, the industry’s first holder-free, self-contained Tangential Flow Filtration (TFF) device. The technology is especially suited to the manufacture of biologics where fully closed systems are critical or ideal, including antibody drug conjugates (ADCs), viral vectors, nucleic acids and lipid nanoparticles, and can also be applied to monoclonal antibody, and recombinant protein production. TangenX SC is not only transformative, it is also a milestone achievement in the advancement of downstream flat sheet TFF technology for ultrafiltration and diafiltration (UF/DF), which is performed in nearly every biopharmaceutical manufacturing process to concentrate and purify drug. Christine Gebski, Senior Vice President, Filtration and
corporate icon
Downstream Filtration
• KrosFlo® TFF  Systems • ProConnex® Flow Paths • TangenX® Cassettes • Hollow Fiber Filters  • KrosFlo® KR2i RPM™ System